Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Rick Bernstein

Thoracic Surgery (Cardiothoracic Vascular Surgery) Las Vegas, NV Medical Doctor

NPI 1932182029 CMS profile 313909

4275 Burnham Ave Ste 102, Las Vegas, NV 89119

Open in the dashboard

General payments

$15,711

171 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Rick Bernstein of Las Vegas, NV is reported in the CMS Open Payments database as having received $15,711 across 171 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 75th percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,880 22
2024 General $1,681 23
2023 General $384 15
2022 General $3,712 49
2021 General $4,364 25
2020 General $328 12
2019 General $3,362 25

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Rick Bernstein
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to Rick Bernstein were reported at $1,880. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year Rick Bernstein Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $3,362 $886 $178–$3,167 $163
2020 $328 $341 $108–$1,605 $114
2021 $4,364 $453 $125–$1,886 $132
2022 $3,712 $695 $180–$2,566 $149
2023 $384 $745 $205–$2,662 $160
2024 $1,681 $799 $214–$2,967 $164
2025 $1,880 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Cardiovascular Systems Inc. $5,805 23 payments
  2. Medtronic, Inc. $2,008 23 payments
  3. Bard Peripheral Vascular, Inc. $1,910 16 payments
  4. Abbott Laboratories $1,704 17 payments
  5. AngioDynamics, Inc. $1,094 10 payments
  6. Cook Medical LLC $882 36 payments
  7. EKOS Corporation $720 2 payments
  8. Endologix, Inc. $547 2 payments
  9. Philips Electronics North America Corporation $321 13 payments
  10. Terumo Medical Corporation $149 6 payments
  11. Other $573 23 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $5,292 20 payments
  2. Compensation for serving as faculty or as a speaker for a medical education program $5,240 3 payments
  3. Food and Beverage $5,179 148 payments
Products named General payments · program years 2019–2025
  1. Diamondback Peripheral $5,378 12 payments
  2. PERCLOSE PROGLIDE $1,542 13 payments
  3. ALPHAVAC $987 2 payments
  4. TurboHawk $892 5 payments
  5. IN.PACT Admiral $871 10 payments
  6. VENOVO $846 3 payments
  7. EKOSONIC $720 2 payments
  8. AFX $544 1 payment
  9. Zilver PTX $446 18 payments
  10. Peripheral Orbital Atherectomy System $427 11 payments
  11. Other $2,671 101 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 4 drugs

Part D claims

166

Median for Thoracic Surgery: 42

Drug cost

$56,445

Median for Thoracic Surgery: $318

Branded share of claims

79.5%

Median for Thoracic Surgery: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Xarelto Rivaroxaban Brand 60 $43,702
Eliquis Apixaban Brand 17 $11,955
Cilostazol Generic 34 $427
Clopidogrel Clopidogrel Bisulfate Brand 55 $362

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 910 Part D prescribers listed as Thoracic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 33 billing codes

Paid by Medicare

$169,348

Medicare's payments for the services billed

Medicare patients

106

Average age 73

Services billed

485

48 women, 58 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 55%
Ischemic heart disease 50%
Diabetes 49%
Chronic kidney disease 36%
Heart failure 29%
COPD 26%
Depression 22%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

171 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Thoracic Surgery (Cardiothoracic Vascular Surgery) in Nevada

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record